RT Journal Article SR Electronic T1 Ambulatory detection of isolated REM sleep behavior disorder combining actigraphy and clinical questionnaire JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.04.21.22274011 DO 10.1101/2022.04.21.22274011 A1 Andreas Brink-Kjaer A1 Niraj Gupta A1 Eric Marin A1 Jennifer Zitser A1 Oliver Sum-Ping A1 Anahid Hekmat A1 Flavia Bueno A1 Ana Cahuas A1 James Langston A1 Poul Jennum A1 Helge B.D. Sorensen A1 Emmanuel Mignot A1 Emmanuel During YR 2022 UL http://medrxiv.org/content/early/2022/04/27/2022.04.21.22274011.abstract AB Importance Isolated rapid-eye-movement sleep behavior disorder (iRBD) is in most cases a prodrome of neurodegenerative synucleinopathies, affecting 1-2 % of middle-aged and older adults, however accurate ambulatory diagnostic methods are lacking. Questionnaires lack specificity in non-clinic populations. Wrist actigraphy can detect characteristic features in individuals with RBD, however high frequency actigraphy has rarely been used.Objective To develop a machine learning classifier using high frequency (1-second resolution) actigraphy and a short patient survey for detecting iRBD with high accuracy and precision.Design Analysis of ≥7 nights home actigraphy data and 9-item questionnaire (RBD Innsbruck inventory and 3 prodromal synucleinopathy symptoms) in a dataset including patients with iRBD, sleep clinic patients with other sleep disorders, and community controls.Setting Single-center study at the Stanford Sleep Center.Participants Of 108 participants, 83 completed the study, including 41 definitive iRBD cases, and 42 age-and sex-matched controls, including 21 sleep clinic patients with RBD mimics (other parasomnias, sleep apnea, periodic limb movements) or other sleep disorders, and 21 community controls.Exposure No interventionMain Outcomes Sensitivity, specificity, accuracy, and precision of classifiers based on actigraphy, on questionnaire data, and both.Results The actigraphy classifier achieved 95.1% (95 % CI: 88.1 - 98.7) sensitivity and 92.9% (95 % CI: 84.9 - 97.3) precision using all nights recorded, and 88.5 % sensitivity and 90.1 % precision over one night, with performance plateauing after 7 to 10 nights. The questionnaire classifier achieved 91.6 % accuracy and 92.5 % precision, exceeding performance of questionnaire alone. Concordant predictions between actigraphy and questionnaire reached specificity and precision of 100 % (95 % CI: 95.7 - 100.0) with 87.8 % sensitivity (95 % CI: 79.0 - 94.1).Conclusions and Relevance Actigraphy detected iRBD with high accuracy in a mixed clinical and community cohort. Combined with a short clinical questionnaire, performance reached 100% precision and 87.8% sensitivity. This fully remote procedure can be used to diagnose iRBD in specialty outpatient settings. This cost-effective method has potential for large scale screening of iRBD in the general population.Question Can ambulatory actigraphy and a short prodromal synucleinopathy questionnaire increase the accuracy of RBD screening?Findings In a dataset of 41 iRBD cases and 42 clinic and community controls, the combination of actigraphy and a 9-item questionnaire reached specificity of 100 % (95% CI: 95.7 - 100.0) and sensitivity of 87.8 % (95% CI: 79.0 - 94.1).Meaning Combination of ambulatory actigraphy and questionnaire can be used in both general and specialty outpatient settings for detecting individuals at high risk of having iRBD. This cost-effective, multimodal strategy has potential for large scale screening in the general population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Feldman Foundation CA. Additional support to Andreas Brink-Kjaer was provided by the Stibo, Oberstloejtnant Max Noergaard & Hustru Magda Noergaards, Otto Moensted, Augustinus, Knud Hoejgaard, William Demant, Vera & Carl Johan Michaelsens, Tranes, Marie & M.B. Richters Fond, and IDAs & Berg-Nielsens foundations.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of Stanford and all participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors-